Burkitt-like lymphoma in a pediatric patient with familial adenomatous polyposis
Katie M Strobel1, Jacquelyn N Crane2, Kathryn L Bradford2
1Department of Pediatrics, University of California Los Angeles Mattel Children's Hospital, Los Angeles, CA, United States.
Abstract:
Familial adenomatous polyposis (FAP) is an autosomal dominant condition that predisposes to multiple malignancies, most commonly colorectal carcinoma, but has rarely been associated with lymphoma. We discuss one patient found to have Burkitt-like Lymphoma (BLL) with 11q aberration in the setting of previously undiagnosed FAP. We review the literature of FAP and associated malignancies and the provisional WHO classification of Burkitt-like lymphoma with 11q aberration. Both FAP and Burkitt-like lymphoma with 11q aberration involve perturbation of the MYC network and this may provide insight into a connection between these two diagnoses. However, further study is needed to elucidate if there is an increased risk of BLL and other subtypes of lymphoma among patients with FAP in order to provide optimal counseling and surveillance for patients with FAP.
Related Concept Videos
05:58Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format
10:02Whole-body PET/MRI of Pediatric Patients: The Details That Matter
Protein Families
Pharmacokinetics in Pediatric Patients: Drug Excretion
Gene Families
Occasionally these regions can be adapted to take on new roles within the organism, becoming novel genes...
Pharmacokinetics in Pediatric Patients: Drug Distribution


